Keeps BioPharma Inc (256940)

Currency in KRW
9,850
+100(+1.03%)
Closed·
256940 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9,5909,940
52 wk Range
6,38022,150
Key Statistics
Bid/Ask
9,850.00 / 9,880.00
Prev. Close
9,750
Open
9,750
Day's Range
9,590-9,940
52 wk Range
6,380-22,150
Volume
118.27K
Average Volume (3m)
158.92K
1-Year Change
49.696%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
256940 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
13,000
Upside
+31.98%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell

Keeps BioPharma Company Profile

Keeps Biopharma Inc. engages in the research, development, production, and sale of mechanical equipment for manufacturing flat panel displays in South Korea, China, and internationally. It offers OLED equipment, inspection technologies, camera modules, precision systems, and TSP/solar products. The company is also involved in bio research and development business; waste battery recycling; and other non-ferrous metal smelting, refining, and alloy manufacturing. The company was formerly known as KPS Corporation and changed its name to Keeps Biopharma Inc. in April 2025. Keeps Biopharma Inc. was founded in 2000 and is headquartered in Hwaseong-si, South Korea.

Compare 256940 to Peers and Sector

Metrics to compare
256940
Peers
Sector
Relationship
P/E Ratio
−6,976.9x−5.7x12.4x
PEG Ratio
69.490.120.01
Price/Book
2.6x1.2x2.4x
Price / LTM Sales
1.3x0.9x2.4x
Upside (Analyst Target)
32.0%25.3%19.5%
Fair Value Upside
Unlock10.8%3.7%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 13,000
(+31.98% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 14, 2025
EPS / Forecast
-22.00 / --
Revenue / Forecast
40.93B / 66.10B
EPS Revisions
Last 90 days

People Also Watch

19,090
290740
+1.27%
11,200
212560
-7.59%
17,650
110990
-0.17%
107,200
000640
+2.29%
26,550
089890
+2.51%

FAQ

What Is the Keeps BioPharma (256940) Share Price Today?

The live Keeps BioPharma share price today is 9,850

What Stock Exchange Does Keeps BioPharma (256940) Trade On?

Keeps BioPharma is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for Keeps BioPharma?

The stock symbol (also called a 'ticker') for Keeps BioPharma is "256940."

What Is the Current Keeps BioPharma Market Cap?

As of today, Keeps BioPharma market capitalisation is 197.77B.

What Is Keeps BioPharma's (256940) Earnings Per Share (TTM)?

The Keeps BioPharma EPS is currently -1.47 (Trailing Twelve Months).

When Is the Next Keeps BioPharma Earnings Date?

Keeps BioPharma's next earnings report will be released on 19 Mar 2026.

Is 256940 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Keeps BioPharma moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Keeps BioPharma Stock Split?

Keeps BioPharma has split 1 times. (See the 256940 stock split history page for full effective split date and price information.)

How Many Employees Does Keeps BioPharma Have?

Keeps BioPharma has 109 employees.

What is the current trading status of Keeps BioPharma (256940)?

As of 24 Jan 2026, Keeps BioPharma (256940) is trading at a price of 9,850, with a previous close of 9,750. The stock has fluctuated within a day range of 9,590 to 9,940, while its 52-week range spans from 6,380 to 22,150.

What Is Keeps BioPharma (256940) Price Target According to Analysts?

The average 12-month price target for Keeps BioPharma is KRW13,000, with a high estimate of KRW13000 and a low estimate of KRW13000. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +31.98% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.